血液衍生生物標記市場：按類型、疾病、應用和地區分類

2026年，血液衍生生物標記市場規模估計為85億美元，預計2033年將達到165億美元。預計2026年至2033年，該市場將以7%的複合年成長率成長。

生物標記，或稱為生物標記物，是指能夠反映細胞或生物體在特定時刻所發生狀態的各種指標。血液來源的生物標記在提案新的診斷方法和治療方法非常有效。血液來源的生物標記具有顯著的優勢，即高效且經濟。

市場動態

全球血液衍生生物標記市場的主要企業正致力於採取產品發布、合作和資金籌措等成長策略，預計這些策略將在預測期內推動市場成長。例如，2020年9月，總部位於西好萊塢的腫瘤公司ONCOtracker, Inc.與為全球臨床醫生和實驗室技術人員提供專業診斷產品的The Binding Site Group Ltd.宣布，雙方已達成一項全球獨家許可和合作協議，共同開發一種用於測量sBCMA的新型臨床檢測方法。 sBCMA是一種新型血液衍生生物標記物，可望用於後續觀察和預測常見血液癌症（包括多發性骨髓瘤（MM）和慢性淋巴性白血病（CLL））及其他相關疾病患者的預後。此外，例如，2021年4月，女性健康公司Sera Prognostics獲得了1億美元的E輪資金籌措，用於加速其PreTRM檢測的商業化進程，該檢測用於評估早產風險。 PreTRM 檢測是一種經過臨床檢驗且市售的血液生物標記檢測，能夠對無症狀單胎妊娠的自發性早產風險進行早期、準確和個人化的預測。

本報告的主要特點

• 本報告對全球血液衍生生物標記市場進行了詳細分析，包括市場規模和預測期（2026-2033 年）的複合年成長率，以 2025 年為基準年。
• 此外，它還確定了每個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
• 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
• 本節根據以下參數，對全球血液衍生生物標記市場的主要企業進行介紹：公司概況、產品系列、主要亮點、財務表現和策略。
• 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
• 《全球血液衍生生物標記市場》報告面向該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員可以透過分析全球血液衍生生物標記市場中使用的各種策略矩陣來促進決策。

目錄

第1章：分析目標與假設

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 阻礙因素
  • 市場機遇
• 影響分析
• 市場趨勢
• 主要進展
• 產品核准
• 合作關係、併購
• 監理情勢
• PEST分析
• 波特五力分析
• 流行病學
• 固體管道分析

第4章：血液衍生生物標記市場：按類型分類（2026-2033 年）

• 用於篩檢的生物標記
• 診斷生物標記
• 其他

第5章：血液衍生生物標記市場：依疾病分類（2026-2033 年）

• 癌症
• 神經系統疾病
• 其他

第6章：血液衍生生物標記市場：按應用領域分類（2026-2033 年）

• 診斷
• 藥物發現
• 個人化醫療

第7章 血液衍生生物標記市場：按地區分類（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
• 中東
  • 波灣合作理事會（GCC）國家
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第8章 競爭情勢

• 熱圖分析
• 市佔率分析
• 公司簡介
  • Diadem srl.
  • Proteomedix
  • Cleveland Diagnostics
  • F. Hoffmann-La Roche Ltd
  • GENFIT
  • Nutech Cancer Biomarkers India Pvt Ltd
  • SysmOex Corporation
  • Minomic
  • Creative Diagnostics
  • Eisai Co., Ltd.
  • C2N Diagnostics

第9章

• 參考
• 分析方法
• 關於 Coherent Market Insights

Blood Based Biomarker Market is estimated to be valued at USD 8.5 Bn in 2026 and is expected to reach USD 16.5 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7% from 2026 to 2033.

The term biomarker, or biological marker, refers to a broad range of measures that capture what is happening in a cell or organism at a given moment. Blood-based biomarkers can be effective in formulating new diagnostic and treatment proposals. Blood-based biomarkers have significant advantages of being time and cost-efficient

Market Dynamics

Key players operating in the global blood based biomarker market are focusing on adoption of growth strategies such as product launch, collaboration, and fund raise which are expected to drive the market growth during the forecast period. For instance, in September 2020, ONCOtracker, Inc., a West Hollywood-based oncology company and The Binding Site Group Ltd, provides specialist diagnostic products to clinicians and laboratory professionals worldwide, announced they have entered into an exclusive global license and collaboration agreement to develop a novel clinical laboratory test for measuring sBCMA, a novel blood-based biomarker, which has shown promise to monitor and predict outcomes for patients with common blood-based cancers including multiple myeloma (MM) and chronic lymphocytic leukemia (CLL) and other related conditions. Moreover, for instance, in April 2021, Sera Prognostics, a Women's health company had secured US$100 m in Series E financing to advance the commercialization of its PreTRM test for premature birth risk. The PreTRM test is a clinically validated and commercially available blood-based biomarker test, which offers an early, precise, and individualized risk prediction for spontaneous preterm birth in asymptomatic singleton pregnancies.

Key features of the study

• This report provides an in-depth analysis of the Global Blood Based Biomarker Market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global blood based biomarker market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
• Key companies covered as a part of this study include Diadem srl., Proteomedix, Cleveland Diagnostics, F. Hoffmann-La Roche Ltd, GENFIT, Nutech Cancer Biomarkers India Pvt Ltd, SysmOex Corporation, Minomic, Creative Diagnostics, Eisai Co., Ltd., and C2N Diagnostics
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global blood based biomarker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood based biomarker market

Market Segmentation

• By Type
  • Screening Biomarker
  • Diagnosis Biomarker
  • Others
• By Disease
  • Cancer
  • Neurological Disorders
  • Others
• By Application
  • Diagnostics
  • Drug Discovery
  • Personalized Medicine
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Key Players
  • Diadem srl.
  • Proteomedix
  • Cleveland Diagnostics
  • Hoffmann-La Roche Ltd
  • GENFIT
  • Nutech Cancer Biomarkers India Pvt Ltd
  • SysmOex Corporation
  • Minomic, Creative Diagnostics, Eisai Co., Ltd.
  • C2N Diagnostics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Disease
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Product Approval
• Collaboration/Merge/Acquisition
• Regulatory Landscape
• PEST Analysis
• Porter's Five Forces Analysis
• Epidemiology
• Robust Pipeline Analysis

4. Blood Based Biomarkers Market, By Type, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026- 2033
  • Segment Trends
• Screening Biomarker
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
• Diagnosis Biomarker
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

5. Blood Based Biomarkers Market, By Disease, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
• Neurological Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

6. Blood Based Biomarkers Market, By Application, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2026 - 2033
  • Segment Trends
• Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
• Drug Discovery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
• Personalized Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

7. Blood Based Biomarkers Market, By Region, 2026 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Regions, 2026-2033
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
• Company Profile
  • Diadem srl.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Proteomedix
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Cleveland Diagnostics
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • F. Hoffmann-La Roche Ltd
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • GENFIT
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Nutech Cancer Biomarkers India Pvt Ltd
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • SysmOex Corporation
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Minomic
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Creative Diagnostics
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • Eisai Co., Ltd.
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
  • C2N Diagnostics
• Company Highlights
• Product Portfolio
• Financial Performance
• Recent Highlights
• Market Strategies
• Analyst Views

9. Section

• References
• Research Methodology
• About Us